EMBRACE-STEMI: Drug targeting mitochondria does not reduce infarct size – Healio | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Advertisements

Feeds:: Posts; Comments

« TOTAL: Manual thrombectomy with PCI does not improve outcomes, increases … – Healio

Early invasive strategy benefits elderly patients with non-STEMI, unstable angina – Healio »

EMBRACE-STEMI: Drug targeting mitochondria does not reduce infarct size – Healio

April 21, 2015 by 2012pharmaceutical

SAN DIEGO — The novel drug Bendavia did not meet any of its primary or secondary endpoints in a trial assessing its use prior to primary PCI in patients with STEMI, according to data presented at the American College of Cardiology Scientific Sessions.Patients…

Source: www.healio.com

See on Scoop.it – Cardiovascular Disease: PHARMACO-THERAPY

Advertisements

Posted in Uncategorized | Leave a Comment

Leave a Reply Cancel reply

Enter your comment here...

Fill in your details below or click an icon to log in:

Email (required) (Address never made public)

Name (required)

Website

You are commenting using your WordPress.com account. ( Log Out / Change )

You are commenting using your Google account. ( Log Out / Change )

You are commenting using your Twitter account. ( Log Out / Change )

You are commenting using your Facebook account. ( Log Out / Change )

Connecting to %s

%d bloggers like this: